P4 medicine is the clinical face of systems medicine. It will make blood a diagnostic window for viewing health and disease for the individual. It provides new approaches to discover the drug target. These medicines will necessitate a fundamental change in the business of every sector of health care industry over the next ten years. This will provide challenges to existing companies and opportunities to create new companies.
P4 medicine promises to sharply reverse the ever escalating costs of healthcare – introducing diagnosis to stratify patients and disease, less expensive approaches to drug discovery, preventive medicine and wellness, and exponentially cost‐decreasing measurement technologies. P4 medicine also promises to improve patient outcomes, and to empower both the patient and the physician.
Related Journals of P4 medicine
Journal of Health & Medical Informatics, Medical & Surgical Urology, Translational Medicine, Tropical Medicine & Surgery ,Biology and Medicine, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine], Yale Journal of Biology and Medicine, Yale Journal of Biology and Medicine, WSEAS Transactions on Biology and Biomedicine, Wound Medicine